New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
14:02 EDTVIVOMeridian granted special 510(k) clearance for TRU FLU in H7N9
Meridian Bioscience announced that the company’s TRU FLU assay received FDA clearance for an analytical sensitivity claim for the novel avian Influenza H7N9 strain, A/Anhui/1/2013. TRU FLU is a rapid immunoassay that detects influenza A and influenza B viruses in 15 minutes in human respiratory specimens. The novel avian Influenza A strain H7N9 was first reported in China last March. Since then, there have been 147 confirmed human cases of avian influenza A H7N9, with 47 deaths reported in China, the company said.
News For VIVO From The Last 14 Days
Check below for free stories on VIVO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for VIVO

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use